Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epidermal growth factor receptor directed therapy in head and neck cancer.
Choong NW, Cohen EE. Choong NW, et al. Among authors: cohen ee. Crit Rev Oncol Hematol. 2006 Jan;57(1):25-43. doi: 10.1016/j.critrevonc.2005.06.002. Epub 2005 Oct 3. Crit Rev Oncol Hematol. 2006. PMID: 16207530 Review.
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Hoffman PC, et al. Among authors: cohen ee. Lung Cancer. 2002 Oct;38(1):65-71. doi: 10.1016/s0169-5002(02)00144-7. Lung Cancer. 2002. PMID: 12367795 Clinical Trial.
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Cohen EE, et al. J Clin Oncol. 2003 May 15;21(10):1980-7. doi: 10.1200/JCO.2003.10.051. J Clin Oncol. 2003. PMID: 12743152 Clinical Trial.
Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
Cohen EE, Vokes EE. Cohen EE, et al. Hematol Oncol Clin North Am. 2004 Feb;18(1):81-90. doi: 10.1016/s0889-8588(03)00148-5. Hematol Oncol Clin North Am. 2004. PMID: 15005282 Review.
The expanding role of systemic therapy in head and neck cancer.
Cohen EE, Lingen MW, Vokes EE. Cohen EE, et al. J Clin Oncol. 2004 May 1;22(9):1743-52. doi: 10.1200/JCO.2004.06.147. J Clin Oncol. 2004. PMID: 15117998 Review.
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Mehta N, et al. Among authors: cohen ee. Int J Oncol. 2004 Dec;25(6):1677-83. Int J Oncol. 2004. PMID: 15547705 Clinical Trial.
Novel therapeutic targets in squamous cell carcinoma of the head and neck.
Cohen EE. Cohen EE. Semin Oncol. 2004 Dec;31(6):755-68. doi: 10.1053/j.seminoncol.2004.09.010. Semin Oncol. 2004. PMID: 15599853 Review.
State-of-the-art management of locally advanced head and neck cancer.
Seiwert TY, Cohen EE. Seiwert TY, et al. Among authors: cohen ee. Br J Cancer. 2005 Apr 25;92(8):1341-8. doi: 10.1038/sj.bjc.6602510. Br J Cancer. 2005. PMID: 15846296 Free PMC article. Review.
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
Cohen EE, Lingen MW, Martin LE, Harris PL, Brannigan BW, Haserlat SM, Okimoto RA, Sgroi DC, Dahiya S, Muir B, Clark JR, Rocco JW, Vokes EE, Haber DA, Bell DW. Cohen EE, et al. Clin Cancer Res. 2005 Nov 15;11(22):8105-8. doi: 10.1158/1078-0432.CCR-05-0926. Clin Cancer Res. 2005. PMID: 16299242
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Cohen EE, et al. Clin Cancer Res. 2005 Dec 1;11(23):8418-24. doi: 10.1158/1078-0432.CCR-05-1247. Clin Cancer Res. 2005. PMID: 16322304 Clinical Trial.
209 results
Jump to page
Feedback